|
1
|
König IR, Fuchs O, Hansen G, von Mutius E
and Kopp MV: What is precision medicine? Eur Respir J.
50:17003912017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Theodoridou M: RSV and precision medicine:
Time for a more precise approach to diagnosis, treatment and
prevention. Int J Mol Med. 44:S322019.
|
|
3
|
Barr R, Green CA, Sande CJ and Drysdale
SB: Respiratory syncytial virus: Diagnosis, prevention and
management. Ther Adv Infect Dis. 6:20499361198657982019.PubMed/NCBI
|
|
4
|
Li Y, Reeves RM, Wang X, Bassat Q, Brooks
WA, Cohen C, Moore DP, Nunes M, Rath B, Campbell H, et al RSV
Global Epidemiology Network; RESCEU investigators: Global patterns
in monthly activity of influenza virus, respiratory syncytial
virus, parainfluenza virus, and metapneumovirus: A systematic
analysis. Lancet Glob Health. 7:e1031–e1045. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alchikh M, Conrad T, Hoppe C, Ma X,
Broberg E, Penttinen P, Reiche J, Biere B, Schweiger B and Rath B:
Are we missing respiratory viral infections in infants and
children? Comparison of a hospital-based quality management system
with standard of care. Clin Microbiol Infect. 25:380.e9–380.e16.
2019. View Article : Google Scholar
|
|
6
|
Blount RE Jr, Morris JA and Savage RE:
Recovery of cytopathogenic agent from chimpanzees with coryza. Proc
Soc Exp Biol Med. 92:544–549. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kapikian AZ, Morens DM and Fauci AS: In
Memoriam: Robert M. Chanock, MD, 1924-2010. J Infect Dis. 203:3–5.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gagliardi TB, Criado MF, Proença-Módena
JL, Saranzo AM, Iwamoto MA, de Paula FE, Cardoso RS, Delcaro LS,
Silva ML, Câmara AA, et al: Syncytia induction by clinical isolates
of human respiratory syncytial virus A. Intervirology. 60:56–60.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mammas IN and Spandidos DA: Updating
taxonomy changes: RSV is now known as Orthopneumovirus. Int J Mol
Med. 44:S312019.
|
|
10
|
ICTV Taxonomy history: Human
orthopneumovirus. International Committee on Taxonomy of Viruses
(ICTV). 2019, https://talk.ictvonline.org/taxonomy/.
|
|
11
|
Karampatsas K, Kong J and Cohen J:
Bronchiolitis: An update on management and prophylaxis. Br J Hosp
Med (Lond). 80:278–284. 2019. View Article : Google Scholar
|
|
12
|
Cunningham S: Respiratory Support in
Bronchiolitis: Trial Evidence. Am J Perinatol. 35:553–556. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rath B, Maltezou HC, Papaevangelou V,
Papagrigoriou-Theodoridou MA, Alchikh M, Myles P and Schweiger B;
PEDSIDEA Network: Partnering for enhanced digital surveillance of
influenza‑like disease and the effect of antivirals and vaccines
(PEDSIDEA). Influenza Other Respir Viruses. 13:309–318. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nair H, Brooks WA, Katz M, Roca A, Berkley
JA, Madhi SA, Simmerman JM, Gordon A, Sato M, Howie S, et al:
Global burden of respiratory infections due to seasonal influenza
in young children: A systematic review and meta-analysis. Lancet.
378:1917–1930. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou H, Thompson WW, Viboud CG, Ringholz
CM, Cheng PY, Steiner C, Abedi GR, Anderson LJ, Brammer L and Shay
DK: Hospitalizations associated with influenza and respiratory
syncytial virus in the United States, 1993-2008. Clin Infect Dis.
54:1427–1436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Homaira N, Mallitt KA, Oei JL, Hilder L,
Bajuk B, Lui K, Rawlinson W, Snelling T and Jaffe A: Risk factors
associated with RSV hospitalisation in the first 2 years of life,
among different subgroups of children in NSW: A
whole-of-population-based cohort study. BMJ Open. 6:e0113982016.
View Article : Google Scholar
|
|
17
|
Shi T, McAllister DA, O'Brien KL, Simoes
EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo
C, et al: RSV Global Epidemiology Network: Global, regional, and
national disease burden estimates of acute lower respiratory
infections due to respiratory syncytial virus in young children in
2015: A systematic review and modelling study. Lancet. 390:946–958.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Broberg EK, Waris M, Johansen K, Snacken R
and Penttinen P; European Influenza Surveillance Network.
Seasonality and geographical spread of respiratory syncytial virus
epidemics in 15 European countries 2010 to 2016. Euro Surveill.
23:232018. View Article : Google Scholar
|
|
19
|
Boeckh M, Chien J, Daniel G, Daniels S,
Dubovsky F, Cody Meissner H, McClellan M, Munoz FM, Murray JS, Rath
BA, et al: Advancing Drug Development for Respiratory Syncytial
Virus. Duke; Washington, DC: 2016, https://healthpolicy.duke.edu/events/advancing-drug-development-respiratory-syncytial-virus
Accessed May 2, 2016.
|
|
20
|
European Centre for Disease Prevention and
Control (ECDC): Technical Workshop: Burden of RSV disease in
Europe. ECDC; Solna: 2015, https://ecdc.europa.eu/en/news-events/technical-workshop-burden-rsv-disease-europe.
Accessed January 3, 2018.
|
|
21
|
Alchikh M, Hoppe C, Conrad T, Schweiger B
and Rath B: Are we missing respiratory viral infections in infants
and children? Comparison of a hospital-based quality management
system with standard of care. ESCMID. 25:380.e9–380.e16. 2019.
|
|
22
|
Rath B and Penttinen P: Incidence,
severity and impact of influenza: A joint meeting organised by the
ISIRV Epidemiology Group and ECDC, Stockholm, 2019. Euro Surveill.
24:19003482019. View Article : Google Scholar :
|
|
23
|
Ma X, Alchikh M, Conrad T, et al: Can we
Distinguish Respiratory Viral Infections based on Clinical
Symptoms? Lessons from a Pediatric Inception Cohort. In:
Proceedings of the ASM2017 Microbe American Society for
Microbiology Conference; New Orleans, LA. 2017
|
|
24
|
Tuttle R, Weick A, Schwarz WS, Chen X,
Obermeier P, Seeber L, Tief F, Muehlhans S, Karsch K, Peiser C, et
al: Evaluation of novel second‑generation RSV and influenza rapid
tests at the point of care. Diagn Microbiol Infect Dis. 81:171–176.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rath B: Vienna Vaccine Safety Initiative.
Hum Vaccin Immunother. 14:1038–1041. 2018. View Article : Google Scholar :
|
|
26
|
Rath B, Ali M, Codarini G, Elemuwa C,
Khamesipour A, Maurer W, Mworozi E, Rundblad G, Varughese S and
Kochhar S: Promoting evidence-based vaccine safety research and
communication - the Vienna Vaccine Safety Initiative. J Trop
Pediatr. 58:167–169. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rath B, Conrad T, Myles P, Alchikh M, Ma
X, Hoppe C, Tief F, Chen X, Obermeier P, Kisler B, et al: Influenza
and other respiratory viruses: Standardizing disease severity in
surveillance and clinical trials. Expert Rev Anti Infect Ther.
15:545–568. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rath B, Maltezou HC, Papaevangelou V,
Papagrigoriou-Theodoridou MA, Alchikh M, Myles P, Schweiger B,
Asimaki H, Dimopoulou D, Hoppe C, et al: PEDSIDEA Network:
Partnering for enhanced digital surveillance of influenza‑like
disease and the effect of antivirals and vaccines (PEDSIDEA).
Influenza Other Respir Viruses. 13:309–318. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rath B, Conrad T, Myles P, Alchikh M, Ma
X, Hoppe C, Tief F, Chen X, Obermeier P, Kisler B and Schweiger B:
The ViVI Disease Severity Score: Enabling Real-time Surveillance of
Influenza Disease Severity for Multi-dimensional Mapping. In:
Proceedings of 25th International Biodetection Technologies
Conference 2017, Biodefense World Summit; Alexandria, VA. 2017
|
|
30
|
Griffiths C, Drews SJ and Marchant DJ:
Respiratory syncytial virus: Infection, detection, and new options
for prevention and treatment. Clin Microbiol Rev. 30:277–319. 2017.
View Article : Google Scholar :
|
|
31
|
Kozanidou E and Achtsidis V: RSV
infection: Not for children only. Int J Mol Med. 44:S322019.
|
|
32
|
Falsey AR, Hennessey PA, Formica MA, Cox C
and Walsh EE: Respiratory syncytial virus infection in elderly and
high-risk adults. N Engl J Med. 352:1749–1759. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Branche AR and Falsey AR: Respiratory
syncytial virus infection in older adults: An under-recognized
problem. Drugs Aging. 32:261–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Blanco JCG, Boukhvalova MS, Morrison TG
and Vogel SN: A multifaceted approach to RSV vaccination. Hum
Vaccin Immunother. 14:1734–1745. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mammas IN and Spandidos DA: Overlap
between RSV, influenza viruses and human metapneumovirus in
childhood. Int J Mol Med. 44:S432019.
|
|
36
|
Koutsounaki E: The neonatal immune
response to RSV infection: Advances in our understanding of viral
and host cellular interactions. Int J Mol Med. 44:S432019.
|
|
37
|
Collins PL and Graham BS: Viral and host
factors in human respiratory syncytial virus pathogenesis. J Virol.
82:2040–2055. 2008. View Article : Google Scholar :
|
|
38
|
Scheltema NM, Kavelaars XM, Thorburn K,
Hennus MP, van Woensel JB, van der Ent CK, Borghans JAM, Bont LJ
and Drylewicz J: Potential impact of maternal vaccination on
life-threatening respiratory syncytial virus infection during
infancy. Vaccine. 36:4693–4700. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mammas IN, Greenough A, Theodoridou M,
Kramvis A, Rusan M, Melidou A, Korovessi P, Papaioannou G,
Papatheodoropoulou A, Koutsaftiki C, et al: Paediatric Virology and
its interaction between basic science and clinical practice
(Review). Int J Mol Med. 41:1165–1176. 2018.PubMed/NCBI
|
|
40
|
Aranda SS and Polack FP: Prevention of
pediatric respiratory syncytial virus lower respiratory tract
illness: Perspectives for the next decade. Front Immunol.
10:10062019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goritzka M, Durant LR, Pereira C,
Salek-Ardakani S, Openshaw PJ and Johansson C: Alpha/beta
interferon receptor signaling amplifies early proinflammatory
cytokine production in the lung during respiratory syncytial virus
infection. J Vir ol. 88:6128–6136. 2014.
|
|
42
|
Sun Y and López CB: The innate immune
response to RSV: Advances in our understanding of critical viral
and host factors. Vaccine. 35:481–488. 2017. View Article : Google Scholar
|
|
43
|
Caballero MT, Serra ME, Acosta PL, Marzec
J, Gibbons L, Salim M, Rodriguez A, Reynaldi A, Garcia A, Bado D,
et al: TLR4 genotype and environmental LPS mediate RSV
bronchiolitis through Th2 polarization. J Clin Invest. 125:571–582.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Drysdale SB, Prendergast M, Alcazar M,
Wilson T, Smith M, Zuckerman M, Broughton S, Rafferty GF, Johnston
SL, Hodemaekers HM, et al: Genetic predisposition of RSV
infection-related respiratory morbidity in preterm infants. Eur J
Pediatr. 173:905–912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Restori KH, Srinivasa BT, Ward BJ and
Fixman ED: Neonatal immunity, respiratory virus infections, and the
development of asthma. Front Immunol. 9:12492018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Varricchi G, Harker J, Borriello F, Marone
G, Durham SR and Shamji MH: T follicular helper (Tfh) cells in
normal immune responses and in allergic disorders. Allergy.
71:1086–1094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Blanken MO, Rovers MM, Molenaar JM,
Winkler-Seinstra PL, Meijer A and Kimpen JL: Respiratory syncytial
virus and recurrent wheeze in healthy preterm infants. N Engl J
Med. 368:1791–1799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Koutsaftiki C: MicroRNAs as potential
biomarkers in children with RSV infection. Int J Mol Med.
44:S322019.
|
|
49
|
Głobińska A, Pawełczyk M and Kowalski ML:
MicroRNAs and the immune response to respiratory virus infections.
Expert Rev Clin Immunol. 10:963–971. 2014. View Article : Google Scholar
|
|
50
|
Rossi GA, Silvestri M and Colin AA:
Respiratory syncytial virus infection of airway cells: Role of
microRNAs. Pediatr Pulmonol. 50:727–732. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kozomara A and Griffiths‑Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42(D1): D68–D73. 2014. View Article : Google Scholar :
|
|
52
|
Maltby S, Plank M, Tay HL, Collison A and
Foster PS: Targeting microRNA function in respiratory diseases:
Mini-review. Front Physiol. 7:212016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Thornburg NJ, Hayward SL and Crowe JE Jr:
Respiratory syncytial virus regulates human microRNAs by using
mechanisms involving beta interferon and NF-κB. MBio. 3:e00220–e12.
2012. View Article : Google Scholar
|
|
54
|
Feng S, Zeng D, Zheng J and Zhao D:
MicroRNAs: Mediators and therapeutic targets to airway hyper
reactivity after respiratory syncytial virus infection. Front
Microbiol. 9:21772018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Anderson L, Jorquera PA and Tripp RA:
MicroRNA profiling from RSV‑infected biofluids, whole blood, and
tissue samples. Methods Mol Biol. 1442:195–208. 2016. View Article : Google Scholar
|
|
56
|
Thibault PA and Wilson JA: Targeting
miRNAs to treat Hepatitis C Virus infections and liver pathology:
Inhibiting the virus and altering the host. Pharmacol Res.
75:48–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mammas IN and Spandidos DA: Thrombocytosis
and RSV infection in hospitalized children with bronchiolitis. Int
J Mol Med. 44:S312019.
|
|
58
|
Chiarello P, Magnolia M, Rubino M, Liguori
SA and Miniero R: Thrombocytosis in children. Minerva Pediatr.
63:507–513. 2011.PubMed/NCBI
|
|
59
|
Schafer AI: Thrombocytosis. N Engl J Med.
350:1211–1219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mantadakis E, Tsalkidis A and
Chatzimichael A: Thrombocytosis in childhood. Indian Pediatr.
45:669–677. 2008.PubMed/NCBI
|
|
61
|
Shin J, Lee DH, Jung N, Choi HJ and Shim
YJ: A cross-sectional retrospective study to analyze the underlying
causes and clinical characteristics of children with reactive
thrombocytosis at a Korean tertiary medical center. Blood Res.
53:233–239. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kubota M, Maeda H, Yoshimoto J, Kobayashi
K, Usami I and Yamaoka K: Thrombocytosis at an early stage of
respiratory tract viral infection. Acta Paediatr. 94:364–366.
2005.PubMed/NCBI
|
|
63
|
Bilavsky E, Yarden-Bilavsky H, Shouval DS,
Fisch N, Garty BZ, Ashkenazi S and Amir J: Respiratory syncytial
virus-positive bronchiolitis in hospitalized infants is associated
with thrombocytosis. Isr Med Assoc J. 12:39–41. 2010.PubMed/NCBI
|
|
64
|
Zheng SY, Xiao QY, Xie XH, Deng Y, Ren L,
Tian DY, Luo ZX, Luo J, Fu Z, Huang AL, et al: Association between
secondary thrombocytosis and viral respiratory tract infections in
children. Sci Rep. 6:229642016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mammas I, Koutsaftiki C,
Tapaki-Papadopoulou G and Myriokefalitakis N: Respiratory syncytial
virus (RSV) bronchiolitis and excessive thrombocytosis. Acta
Paediatr. 99:489–490. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ng KF, Tan KK, Sam ZH, Ting GS and Gan WY:
Epidemiology, clinical characteristics, laboratory findings and
severity of respiratory syncytial virus acute lower respiratory
infection in Malaysian children, 2008-2013. J Paediatr Child
Health. 53:399–407. 2017. View Article : Google Scholar
|
|
67
|
Vlacha V and Feketea G: Thrombocytosis in
pediatric patients is associated with severe lower respiratory
tract inflammation. Arch Med Res. 37:755–759. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Haidopoulou K, Goutaki M, Lemonaki M,
Kavga M and Papa A: Reactive thrombocytosis in children with viral
respiratory tract infections. Minerva Pediatr. 63:257–262.
2011.PubMed/NCBI
|
|
69
|
Indolfi G, Catania P, Bartolini E, Azzari
C, Massai C, Poggi GM, De Martino M and Resti M: Incidence and
clinical significance of reactive thrombocytosis in children aged 1
to 24 months, hospitalized for community-acquired infections.
Platelets. 19:409–414. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Denton A and Davis P: Extreme
thrombocytosis in admissions to paediatric intensive care: No
requirement for treatment. Arch Dis Child. 92:515–516. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Korovessi P: RSV bronchiolitis and
paediatric asthma. Int J Mol Med. 44:S422019.
|
|
72
|
Kabego L and de Beer C: Association
between respiratory syncytial virus infection in infancy and
subsequent asthma: A meta-analysis of observational studies. JSM
Allergy Asthma. 2:10092017.
|
|
73
|
Régnier SA and Huels J: Association
between respiratory syncytial virus hospitalizations in infants and
respiratory sequelae: Systematic review and meta-analysis. Pediatr
Infect Dis J. 32:820–826. 2013.PubMed/NCBI
|
|
74
|
Jartti T, Smits HH, Bønnelykke K, Bircan
O, Elenius V, Konradsen JR, Maggina P, Makrinioti H, Stokholm J,
Hedlin G, et al: EAACI Task Force on Clinical Practice
Recommendations on Preschool Wheeze: Bronchiolitis needs a revisit:
Distinguishing between virus entities and their treatments.
Allergy. 74:40–52. 2019. View Article : Google Scholar
|
|
75
|
Fauroux B, Simões EAF, Checchia PA, Paes
B, Figueras-Aloy J, Manzoni P, Bont L and Carbonell-Estrany X: The
burden and long-term respiratory morbidity associated with
respiratory syncytial virus infection in early childhood. Infect
Dis Ther. 6:173–197. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Homaira N, Briggs N, Pardy C, Hanly M, Oei
JL, Hilder L, Bajuk B, Lui K, Rawlinson W, Snelling T, et al:
Association between respiratory syncytial viral disease and the
subsequent risk of the first episode of severe asthma in different
subgroups of high-risk Australian children: A
whole-of-population-based cohort study. BMJ Open. 7:e0179362017.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Thomsen SF, van der Sluis S, Stensballe
LG, Posthuma D, Skytthe A, Kyvik KO, Duffy DL, Backer V and
Bisgaard H: Exploring the association between severe respiratory
syncytial virus infection and asthma: A registry-based twin study.
Am J Respir Crit Care Med. 179:1091–1097. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Mochizuki H, Kusuda S, Okada K, Yoshihara
S, Furuya H, Simões EAF, Asanuma H, Yoshida H, Katayose M, Imamura
T, et al: Scientific Committee for Elucidation of Infantile Asthma:
Palivizumab prophylaxis in preterm infants and subsequent recurrent
wheezing. Six-year follow-up study. Am J Respir Crit Care Med.
196:29–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Scheltema NM, Nibbelke EE, Pouw J, Blanken
MO, Rovers MM, Naaktgeboren CA, Mazur NI, Wildenbeest JG, van der
Ent CK and Bont LJ: Respiratory syncytial virus prevention and
asthma in healthy preterm infants: A randomised controlled trial.
Lancet Respir Med. 6:257–264. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Carbonell-Estrany X, Pérez-Yarza EG,
García LS, Guzmán Cabañas JM and Bòria EV: Long-term burden and
respiratory effects of respiratory syncytial virus hospitalization
in preterm infants - The SPRING Study. PLoS One. 10:e01254222015.
View Article : Google Scholar
|
|
81
|
Lukkarinen M, Koistinen A, Turunen R,
Lehtinen P, Vuorinen T and Jartti T: Rhinovirus‑induced first
wheezing episode predicts atopic but not nonatopic asthma at school
age. J Allergy Clin Immunol. 140:988–995. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Rubner FJ, Jackson DJ, Evans MD, Gangnon
RE, Tisler CJ, Pappas TE, Gern JE and Lemanske RF Jr: Early life
rhinovirus wheezing, allergic sensitization, and asthma risk at
adolescence. J Allergy Clin Immunol. 139:501–507. 2017. View Article : Google Scholar
|
|
83
|
Koutsaftiki C: Predicting asthma following
RSV-positive bronchiolitis in early childhood. Int J Mol Med.
44:S312019.
|
|
84
|
Drysdale SB, Alcazar-Paris M, Wilson T,
Smith M, Zuckerman M, Peacock JL, Johnston SL and Greenough A:
Viral lower respiratory tract infections and preterm infants'
healthcare utilisation. Eur J Pediatr. 174:209–215. 2015.
View Article : Google Scholar
|
|
85
|
Drysdale SB, Milner AD and Greenough A:
Respiratory syncytial virus infection and chronic respiratory
morbidity - is there a functional or genetic predisposition? Acta
Paediatr. 101:1114–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Gern JE: Viral respiratory infection and
the link to asthma. Pediatr Infect Dis J. 27(Suppl): S97–S103.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Bacharier LB, Cohen R, Schweiger T,
Yin-Declue H, Christie C, Zheng J, Schechtman KB, Strunk RC and
Castro M: Determinants of asthma after severe respiratory syncytial
virus bronchiolitis. J Allergy Clin Immunol. 130:91–100.e3. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lu S, Hartert TV, Everard ML, Giezek H,
Nelsen L, Mehta A, Patel H, Knorr B and Reiss TF: Predictors of
asthma following severe respiratory syncytial virus (RSV)
bronchiolitis in early childhood. Pediatr Pulmonol. 51:1382–1392.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Jartti T and Gern JE: Role of viral
infections in the development and exacerbation of asthma in
children. J Allergy Clin Immunol. 140:895–906. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Grivas G, Lymperatou C and Korovessi P:
Post infectious bronchiolitis obliterans caused by respiratory
syncytial virus (RSV) in children. Int J Mol Med. 44:S422019.
|
|
91
|
Kavaliunaite E and Aurora P: Diagnosing
and managing bronchiolitis obliterans in children. Expert Rev
Respir Med. 13:481–488. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Champs NS, Lasmar LM, Camargos PA, Marguet
C, Fischer GB and Mocelin HT: Post-infectious bronchiolitis
obliterans in children. J Pediatr (Rio J). 87:187–198. 2011.
|
|
93
|
Rodríguez DA, Rodríguez-Martínez CE,
Cárdenas AC, Quilaguy IE, Mayorga LY, Falla LM and Nino G:
Predictors of severity and mortality in children hospitalized with
respiratory syncytial virus infection in a tropical region. Pediatr
Pulmonol. 49:269–276. 2014. View Article : Google Scholar :
|
|
94
|
Wu XY, Luo ZX, Fu Z, Liu EM, Luo J and He
L: Clinical analysis of 28 cases of bronchiolitis obliterans.
Zhongguo Dang Dai Er Ke Za Zhi. 15:845–849. 2013.In Chinese.
PubMed/NCBI
|
|
95
|
Yanagisawa J, Shiraishi T, Okamatsu Y and
Iwasaki A: Successful lung volume reduction surgery in an infant
with emphysema after respiratory syncytial virus-induced
obliterative bronchiolitis. J Thorac Cardiovasc Surg. 145:e47–e49.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Chen DH, Lin YN, Lan SL, Pan XA, Zeng QS,
He ZT, Liang M, Zhang BY, Wu SZ, Xu JX, et al: Clinical
characteristics of bronchiolitis obliterans in pediatric patients.
Zhonghua Er Ke Za Zhi. 50:98–102. 2012.In Chinese. PubMed/NCBI
|
|
97
|
Giovannini-Chami L, Khirani S, Thouvenin
G, Ramirez A and Fauroux B: Work of breathing to optimize
noninvasive ventilation in bronchiolitis obliterans. Intensive Care
Med. 38:722–724. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Sardón O, Pérez-Yarza EG, Aldasoro A,
Corcuera P, Mintegui J and Korta J: Bronchiolitis obliterans:
Outcome in the medium term. An Pediatr (Barc). 76:58–64. 2012.In
Spanish. View Article : Google Scholar
|
|
99
|
Wang W, Shen KL and Zeng JJ: Clinical
studies of children with bronchiolitis obliterans. Zhonghua Er Ke
Za Zhi. 46:732–738. 2008.In Chinese. PubMed/NCBI
|
|
100
|
Lobo AL, Guardiano M, Nunes T, Azevedo I
and Vaz LG: Pos-infectious bronchiolitis obliterans in children.
Rev Port Pneumol. 13:495–509. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Hirschheimer M, Silva PS, Giudici R,
Carrilho M, Mauad T and Ishida M: Simultaneous viral infection and
childhood bronchiolitis obliterans. Braz J Infect Dis. 6:146–148.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Massie R and Armstrong D: Bronchiectasis
and bronchiolitis obliterans post respiratory syncytial virus
infection: Think again. J Paediatr Child Health. 35:497–498. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yalçin E, Doğru D, Haliloğlu M, Ozçelik U,
Kiper N and Göçmen A: Postinfectious bronchiolitis obliterans in
children: Clinical and radiological profile and prognostic factors.
Respiration. 70:371–375. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Papaioannou G: Imaging in children with
RSV infection. Int J Mol Med. 44:S302019.
|
|
105
|
Dawson-Caswell M and Muncie HL Jr:
Respiratory syncytial virus infection in children. Am Fam
Physician. 83:141–146. 2011.PubMed/NCBI
|
|
106
|
National Institute for Health and Care
Excellence (NICE): Bronchiolitis in children: diagnosis and
management, NICE guideline [NG9]. https://www.nice.org.uk/guidance/ng9.
Accessed June 1, 2015.
|
|
107
|
Kern S, Uhl M, Berner R, Schwoerer T and
Langer M: Respiratory syncytial virus infection of the lower
respiratory tract: Radiological findings in 108 children. Eur
Radiol. 11:2581–2584. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Hilmes MA, Daniel Dunnavant F, Singh SP,
Ellis WD, Payne DC, Zhu Y, Griffin MR, Edwards KM and Williams JV:
Chest radiographic features of human metapneumovirus infection in
pediatric patients. Pediatr Radiol. 47:1745–1750. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Alkan Ozdemir S, Ozer EA, Pekcevik Y,
Ilhan O and Sutcuoglu S: Is radiological appearance of lower
respiratory tract infection due to respiratory syncytial virus a
predictor of clinical outcome? J Matern Fetal Neonatal Med.
28:1660–1663. 2015. View Article : Google Scholar
|
|
110
|
Pickles R and DeVincenzo J: PSV and its
propensity for causing bronchioloitis. J Pathol. 235:266–267. 2015.
View Article : Google Scholar
|
|
111
|
Franquet T: Imaging of pulmonary viral
pneumonia. Radiology. 260:18–39. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Xu L, Gao H, Zeng J, Liu J, Lu C, Guan X,
Qian S and Xie Z: A fatal case associated with respiratory
syncytial virus infection in a young child. BMC Infect Dis.
18:2172018. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Park A, Suh SI, Son GR, Lee YH, Seo HS,
Eun BL, Lee NJ and Seol HY: Respiratory syncytial virus-related
encephalitis: Magnetic resonance imaging findings with
diffusion‑weighted study. Neuroradiology. 56:163–168. 2014.
View Article : Google Scholar
|
|
114
|
Al-Maskari N, Mohsin J, Al-Maani A,
Al-Macki N and Al-Ismaili S: Atypical presentations of respiratory
syncytial virus infection: Case series. Sultan Qaboos Univ Med J.
16:e86–e91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Drysdale SB: Management of RSV infection
in children: New advances and challenges. Int J Mol Med.
44:S262019.
|
|
116
|
Krilov LR: Safety issues related to the
administration of ribavirin. Pediatr Infect Dis J. 21:479–481.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Behzadi MA and Leyva-Grado VH: Overview of
current therapeutics and novel candidates against influenza,
respiratory syncytial virus, and Middle East respiratory syndrome
coronavirus infections. Front Microbiol. 10:13272019. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Xing Y and Proesmans M: New therapies for
acute RSV infections: Where are we? Eur J Pediatr. 178:131–138.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Beigel JH, Nam HH, Adams PL, Krafft A,
Ince WL, El-Kamary SS and Sims AC: Advances in respiratory virus
therapeutics - A meeting report from the 6th isirv Antiviral Group
conference. Antiviral Res. 167:45–67. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Nicholson EG and Munoz FM: A review of
therapeutics in clinical development for respiratory syncytial
virus and influenza in children. Clin Ther. 40:1268–1281. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Sherman AC, Mehta A, Dickert NW, Anderson
EJ and Rouphael N: The future of flu: A review of the human
challenge model and systems biology for advancement of influenza
vaccinology. Front Cell Infect Microbiol. 9:1072019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Jozwik A, Habibi MS, Paras A, Zhu J,
Guvenel A, Dhariwal J, Almond M, Wong EHC, Sykes A, Maybeno M, et
al: RSV‑specific airway resident memory CD8+ T cells and
differential disease severity after experimental human infection.
Nat Commun. 6:102242015. View Article : Google Scholar
|
|
123
|
Papatheodoropoulou A: High‑flow warm
humidified oxygen via nasal cannula and RSV-positive bronchiolitis
among children admitted to PICU. Int J Mol Med. 44:S302019.
|
|
124
|
Beggs S, Wong ZH, Kaul S, Ogden KJ and
Walters JA: High‑flow nasal cannula therapy for infants with
bronchiolitis. Cochrane Database Syst Rev. 2014:CD0096092014.
|
|
125
|
Franklin D, Dalziel S, Schlapbach LJ, Babl
FE, Oakley E, Craig SS, Furyk JS, Neutze J, Sinn K, Whitty JA, et
al: PARIS and PREDICT: Early high flow nasal cannula therapy in
bronchiolitis, a prospective randomised control trial (protocol): A
Paediatric Acute Respiratory Intervention Study (PARIS). BMC
Pediatr. 15:1832015. View Article : Google Scholar
|
|
126
|
van Miert C, Fernandes RM, Eccleson H,
Bedson E, Lane S, Peak M, Thorburn K, Compton V, Woolfall K, Lacy
D, et al: Non-invasive ventilation for the management of children
with bronchiolitis (NOVEMBR): A feasibility study and core outcome
set development protocol. Trials. 19:6272018. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Kepreotes E, Whitehead B, Attia J,
Oldmeadow C, Collison A, Searles A, Goddard B, Hilton J, Lee M and
Mattes J: High‑flow warm humidified oxygen versus standard low‑flow
nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): An
open, phase 4, randomised controlled trial. Lancet. 389:930–939.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Franklin D, Babl FE, Schlapbach LJ, Oakley
E, Craig S, Neutze J, Furyk J, Fraser JF, Jones M, Whitty JA, et
al: A randomized trial of high‑flow oxygen therapy in infants with
bronchiolitis. N Engl J Med. 378:1121–1131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Goh CT, Kirby LJ, Schell DN and Egan JR:
Humidified high‑flow nasal cannula oxygen in bronchiolitis reduces
need for invasive ventilation but not intensive care admission. J
Paediatr Child Health. 53:897–902. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Clayton JA, McKee B, Slain KN, Rotta AT
and Shein SL: Outcomes of children with bronchiolitis treated with
high‑flow nasal cannula or noninvasive positive pressure
ventilation. Pediatr Crit Care Med. 20:128–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Milési C, Essouri S, Pouyau R, Liet JM,
Afanetti M, Portefaix A, Baleine J, Durand S, Combes C, Douillard
A, et al: Groupe Francophone de Réanimation et d'Urgences
Pédiatriques (GFRUP): High flow nasal cannula (HFNC) versus nasal
continuous positive airway pressure (nCPAP) for the initial
respiratory management of acute viral bronchiolitis in young
infants: A multicenter randomized controlled trial (TRAMONTANE
study). Intensive Care Med. 43:209–216. 2017. View Article : Google Scholar
|
|
132
|
Papatheodoropoulou A: Heliox and
RSV-positive bronchiolitis. Int J Mol Med. 44:S322019.
|
|
133
|
Hess DR, Fink JB, Venkataraman ST, Kim IK,
Myers TR and Tano BD: The history and physics of heliox. Respir
Care. 51:608–612. 2006.PubMed/NCBI
|
|
134
|
Nascimento MS, Santos É and Prado CD:
Helium-oxygen mixture: Clinical applicability in an intensive care
unit. Einstein (Sao Paulo). 16:eAO41992018. View Article : Google Scholar
|
|
135
|
Barach AL: The therapeutic use of helium.
JAMA. 107:1273–1280. 1936. View Article : Google Scholar
|
|
136
|
Moraa I, Sturman N, McGuire TM and van
Driel ML: Heliox for croup in children. Cochrane Database Syst Rev.
10:CD0068222018.PubMed/NCBI
|
|
137
|
Morgan SE, Vukin K, Mosakowski S, Solano
P, Stanton L, Lester L, Lavani R, Hall JB and Tung A: Use of heliox
delivered via high-flow nasal cannula to treat an infant with
coronavirus‑related respiratory infection and severe acute air-flow
obstruction. Respir Care. 59:e166–e170. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Martinón-Torres F: Noninvasive ventilation
with helium-oxygen in children. J Crit Care. 27:220.e1–220.e9.
2012. View Article : Google Scholar
|
|
139
|
Liet JM, Ducruet T, Gupta V and Cambonie
G: Heliox inhalation therapy for bronchiolitis in infants. Cochrane
Database Syst Rev. (9): CD0069152015.PubMed/NCBI
|
|
140
|
Seliem W and Sultan AM: Heliox delivered
by high flow nasal cannula improves oxygenation in infants with
respiratory syncytial virus acute bronchiolitis. J Pediatr (Rio J).
94:56–61. 2018. View Article : Google Scholar
|
|
141
|
Theodoridou M: Prevention of RSV
infection: What is new with the vaccines? J Mol Med (Berl).
44:S292019.
|
|
142
|
Wang D, Cummins C, Bayliss S, Sandercock J
and Burls A: Immunoprophylaxis against respiratory syncytial virus
(RSV) with palivizumab in children: A systematic review and
economic evaluation. Health Technol Assess. 12:iiiix–x. 1–86. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Modjarrad K, Giersing B, Kaslow DC and
Smith PG: WHO consultation on Respiratory Syncytial Virus Vaccine
Development Report from a World Health Organization Meeting held on
23-24 March 2015. Vaccine. 34:190–197. 2016. View Article : Google Scholar
|
|
144
|
Nair H, Nokes DJ, Gessner BD, Dherani M,
Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, et
al: global burden of acute lower respiratory infections due to
respiratory syncytial virus in young children: A systematic review
and meta-analysis. Lancet. 375:1545–1555. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Gerretsen HE and Sande CJ: Development of
respiratory syncytial virus (RSV) vaccines for infants. J Infect.
74(Suppl 1): S143–S146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Prince GA, Jenson AB, Hemming VG, Murphy
BR, Walsh EE, Horswood RL and Chanock RM: Enhancement of
respiratory syncytial virus pulmonary pathology in cotton rats by
prior intramuscular inoculation of formalin-inactivated virus. J
Virol. 57:721–728. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Graham BS: Vaccine development for
respiratory syncytial virus. Curr Opin Virol. 23:107–112. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Graham BS: Vaccines against respiratory
syncytial virus: The time has finally come. Vaccine. 34:3535–3541.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Widjojoatmodjo MN, Bogaert L, Meek B, Zahn
R, Vellinga Custers J, Serroyen J, Radošević K and Schuitemaker H:
Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35
expressing the respiratory syncytial virus (RSV) fusion protein
induce protective immunity against RSV infection in cotton rats.
Vaccine. 33:5406–5414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Pardi N and Weissman D: Nucleoside
modified mRNA vaccines for infections diseases. Methods Mol Biol.
1499:109–121. 2017. View Article : Google Scholar
|
|
151
|
PATH: RSV vaccine mAb snapshot. https://path.azureedge.net/media/documents/RSV-snapshot-2019_08_28_High_Resolution_PDF.pdf.
Accessed August 28, 2019.
|
|
152
|
Novavax: Prepare™ Trial Topline Results.
https://novavax.com/2019_02_27_ResVax_Draft.pdf.
Accessed February 28, 2019.
|
|
153
|
Patrick M: Will the ResVax vaccine be key
revenue driver for Novavax. Market Realist; 2019, https://marketrealist.com/2019/05/will-the-resvax-vaccine-be-key-revenue-driver-for-novavax/.
Accessed May 6, 2019.
|
